Condensed Consolidated Statements of Income (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net sales	$ 530,644	$ 505,066	$ 1,576,820	$ 1,530,059
Cost of goods sold	242,068	220,850	715,713	674,330
Gross profit	288,576	284,216	861,107	855,729
Selling, general and administrative expense	202,550	202,238	600,663	583,486
Research and Development Expense	52,786	52,920	161,046	155,104
Segment profit (loss)	33,240	29,058	99,398	117,139
Interest expense	7,710	31,611	17,131	54,252
Foreign exchange losses, net	3,667	3,330	6,118	5,723
Other (income) expense, net	(613)	(667)	(9,662)	(10,711)
Income before income taxes	22,476	(5,216)	85,811	67,875
Provision for income taxes	(10,967)	(1,883)	(36,003)	(20,200)
Net income including noncontrolling interests	11,509	(7,099)	49,808	47,675
Net loss (income) attributable to noncontrolling interests	0	0	0	(21)
Net income attributable to Bio-Rad	$ 11,509	$ (7,099)	$ 49,808	$ 47,654
Basic earnings per share:
Net income per share basic attributable to Bio-Rad	$ 0.40	$ (0.25)	$ 1.73	$ 1.67
Weighted average common shares - basic	28,884	28,603	28,834	28,545
Diluted earnings per share:
Net income per share diluted attributable to Bio-Rad	$ 0.39	$ (0.25)	$ 1.71	$ 1.65
Weighted average common shares - diluted	29,141	28,603	29,097	28,870